NVAX · Novavax Inc · Documents
Market Cap
$1.58B
Shares
164.95M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-06-23 | 2026-06-18 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| DEF 14A | 2026-04-27 | 2026-06-18 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-20 | 2026-01-15 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-04 | 2025-11-03 | |
| 8-K | 2025-10-22 | 2025-10-17 | |
| 8-K | 2025-10-07 | 2025-10-01 | |
| 8-K | 2025-08-27 | — | |
| 8-K | 2025-08-27 | — | |
| 8-K | 2025-08-21 | 2025-08-20 | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-06-24 | 2025-06-20 | |
| 8-K | 2025-06-11 | — | |
| 8-K | 2025-05-27 | — | |
| 8-K | 2025-05-19 | 2025-05-16 | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-05 | — | |
| 8-K | 2025-04-29 | 2025-04-25 | |
| DEF 14A | 2025-04-29 | 2025-06-20 | |
| 8-K | 2025-04-23 | — | |
| 8-K | 2025-04-02 | — | |
| 8-K | 2025-03-11 | 2025-03-07 | |
| 8-K | 2025-03-11 | 2025-03-10 | |
| 8-K | 2025-03-04 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-30 | — | |
| 8-K | 2024-12-18 | 2024-12-12 | |
| 8-K | 2024-12-04 | 2024-12-03 | |
| 8-K | 2024-11-20 | 2024-11-19 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-11-12 | 2024-11-11 | |
| 8-K | 2024-11-05 | 2024-11-01 | |
| 8-K | 2024-10-16 | — | |
| 8-K | 2024-10-03 | 2024-10-02 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — |
Showing 1–50 of 169 filings
Key facts
CIK
1000694
CUSIP
670002401
13F (30d)
10 filings
9 filers
Visit website
Investor relations